| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | 1.25e-04 | 1099 | 29 | 8 | GO:0008092 | |
| GeneOntologyMolecularFunction | actin filament binding | 3.09e-04 | 227 | 29 | 4 | GO:0051015 | |
| GeneOntologyMolecularFunction | actin binding | 5.74e-04 | 479 | 29 | 5 | GO:0003779 | |
| GeneOntologyBiologicalProcess | actin filament fragmentation | 9.99e-09 | 4 | 29 | 3 | GO:0030043 | |
| GeneOntologyBiologicalProcess | positive regulation of actin filament depolymerization | 9.00e-07 | 14 | 29 | 3 | GO:0030836 | |
| GeneOntologyBiologicalProcess | actin filament severing | 2.01e-06 | 18 | 29 | 3 | GO:0051014 | |
| GeneOntologyBiologicalProcess | positive regulation of protein depolymerization | 3.27e-06 | 21 | 29 | 3 | GO:1901881 | |
| GeneOntologyBiologicalProcess | actin polymerization or depolymerization | 1.33e-05 | 222 | 29 | 5 | GO:0008154 | |
| GeneOntologyBiologicalProcess | positive regulation of protein-containing complex disassembly | 2.57e-05 | 41 | 29 | 3 | GO:0043243 | |
| GeneOntologyBiologicalProcess | regulation of actin filament organization | 5.61e-05 | 300 | 29 | 5 | GO:0110053 | |
| GeneOntologyBiologicalProcess | actin filament organization | 6.43e-05 | 509 | 29 | 6 | GO:0007015 | |
| GeneOntologyBiologicalProcess | regulation of actin filament depolymerization | 8.51e-05 | 61 | 29 | 3 | GO:0030834 | |
| GeneOntologyBiologicalProcess | regulation of actin polymerization or depolymerization | 1.05e-04 | 177 | 29 | 4 | GO:0008064 | |
| GeneOntologyBiologicalProcess | actin filament depolymerization | 1.08e-04 | 66 | 29 | 3 | GO:0030042 | |
| GeneOntologyBiologicalProcess | regulation of actin filament length | 1.12e-04 | 180 | 29 | 4 | GO:0030832 | |
| GeneOntologyBiologicalProcess | regulation of actin cytoskeleton organization | 1.79e-04 | 384 | 29 | 5 | GO:0032956 | |
| GeneOntologyBiologicalProcess | cytokinesis | 1.82e-04 | 204 | 29 | 4 | GO:0000910 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure size | 1.86e-04 | 618 | 29 | 6 | GO:0090066 | |
| GeneOntologyBiologicalProcess | regulation of actin filament-based process | 3.29e-04 | 438 | 29 | 5 | GO:0032970 | |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | 3.29e-04 | 438 | 29 | 5 | GO:1902903 | |
| GeneOntologyBiologicalProcess | regulation of protein depolymerization | 4.25e-04 | 105 | 29 | 3 | GO:1901879 | |
| GeneOntologyBiologicalProcess | phospholipid biosynthetic process | 5.12e-04 | 268 | 29 | 4 | GO:0008654 | |
| GeneOntologyBiologicalProcess | regulation of establishment of cell polarity | 5.61e-04 | 25 | 29 | 2 | GO:2000114 | |
| GeneOntologyBiologicalProcess | regulation of actin filament bundle assembly | 6.75e-04 | 123 | 29 | 3 | GO:0032231 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | 7.53e-04 | 803 | 29 | 6 | GO:0030036 | |
| GeneOntologyBiologicalProcess | regulation of establishment or maintenance of cell polarity | 8.10e-04 | 30 | 29 | 2 | GO:0032878 | |
| GeneOntologyBiologicalProcess | positive regulation of focal adhesion assembly | 8.65e-04 | 31 | 29 | 2 | GO:0051894 | |
| GeneOntologyBiologicalProcess | protein depolymerization | 1.07e-03 | 144 | 29 | 3 | GO:0051261 | |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex disassembly | 1.07e-03 | 144 | 29 | 3 | GO:0043244 | |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | 1.16e-03 | 579 | 29 | 5 | GO:0051493 | |
| GeneOntologyBiologicalProcess | positive regulation of cell-substrate junction organization | 1.17e-03 | 36 | 29 | 2 | GO:0150117 | |
| GeneOntologyBiologicalProcess | actin filament-based process | 1.46e-03 | 912 | 29 | 6 | GO:0030029 | |
| GeneOntologyBiologicalProcess | negative regulation of actin filament bundle assembly | 1.82e-03 | 45 | 29 | 2 | GO:0032232 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | 1.86e-03 | 957 | 29 | 6 | GO:0097435 | |
| GeneOntologyBiologicalProcess | establishment of cell polarity | 1.93e-03 | 177 | 29 | 3 | GO:0030010 | |
| Domain | ADF/Cofilin | 3.74e-09 | 3 | 30 | 3 | IPR017904 | |
| Domain | ADF | 4.45e-07 | 10 | 30 | 3 | SM00102 | |
| Domain | Cofilin_ADF | 4.45e-07 | 10 | 30 | 3 | PF00241 | |
| Domain | ADF-H | 4.45e-07 | 10 | 30 | 3 | IPR002108 | |
| Domain | ADF_H | 4.45e-07 | 10 | 30 | 3 | PS51263 | |
| Domain | - | 7.40e-06 | 24 | 30 | 3 | 3.40.20.10 | |
| Domain | ADF-H/Gelsolin-like_dom | 7.40e-06 | 24 | 30 | 3 | IPR029006 | |
| Domain | - | 5.05e-03 | 218 | 30 | 3 | 1.10.10.10 | |
| Domain | WHTH_DNA-bd_dom | 6.74e-03 | 242 | 30 | 3 | IPR011991 | |
| Domain | PHD | 8.96e-03 | 89 | 30 | 2 | SM00249 | |
| Domain | Znf_PHD | 9.35e-03 | 91 | 30 | 2 | IPR001965 | |
| Domain | ZF_PHD_2 | 1.02e-02 | 95 | 30 | 2 | PS50016 | |
| Domain | ZF_PHD_1 | 1.04e-02 | 96 | 30 | 2 | PS01359 | |
| Domain | SAM | 1.06e-02 | 97 | 30 | 2 | IPR001660 | |
| Domain | - | 1.25e-02 | 106 | 30 | 2 | 1.10.150.50 | |
| Domain | SAM/pointed | 1.51e-02 | 117 | 30 | 2 | IPR013761 | |
| Pathway | SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES | 1.81e-05 | 35 | 21 | 3 | M16801 | |
| Pathway | WP_G13_SIGNALING | 2.32e-05 | 38 | 21 | 3 | M39606 | |
| Pathway | WP_G13_SIGNALING_PATHWAY | 2.52e-05 | 39 | 21 | 3 | MM15898 | |
| Pathway | SIG_CHEMOTAXIS | 3.88e-05 | 45 | 21 | 3 | M5193 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_ROCKS | 3.56e-04 | 19 | 21 | 2 | M27493 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_RAC_SIGNALING_PATHWAY | 6.72e-04 | 26 | 21 | 2 | M47561 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNB_G_RAC_SIGNALING_PATHWAY | 6.72e-04 | 26 | 21 | 2 | M47562 | |
| Pathway | KEGG_AXON_GUIDANCE | 8.83e-04 | 129 | 21 | 3 | M5539 | |
| Pathway | WP_REGULATION_OF_ACTIN_CYTOSKELETON | 1.36e-03 | 150 | 21 | 3 | M39520 | |
| Pathway | WP_REGULATION_OF_ACTIN_CYTOSKELETON | 1.42e-03 | 152 | 21 | 3 | MM15834 | |
| Pathway | WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION | 1.61e-03 | 159 | 21 | 3 | M48090 | |
| Pathway | REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING | 1.76e-03 | 42 | 21 | 2 | M27308 | |
| Pathway | PID_RHOA_PATHWAY | 2.01e-03 | 45 | 21 | 2 | M12 | |
| Pubmed | 5.79e-10 | 3 | 30 | 3 | 11809832 | ||
| Pubmed | 5.79e-10 | 3 | 30 | 3 | 26996939 | ||
| Pubmed | ADF/Cofilin-Mediated Actin Turnover Promotes Axon Regeneration in the Adult CNS. | 2.32e-09 | 4 | 30 | 3 | 31400829 | |
| Pubmed | Filamin-A regulates actin-dependent clustering of HIV receptors. | 3.23e-08 | 8 | 30 | 3 | 17572668 | |
| Pubmed | ADF/cofilin-mediated actin retrograde flow directs neurite formation in the developing brain. | 6.92e-08 | 10 | 30 | 3 | 23259946 | |
| Pubmed | 2.62e-07 | 15 | 30 | 3 | 24598388 | ||
| Pubmed | Loss of endogenous thymosin β4 accelerates glomerular disease. | 4.68e-07 | 18 | 30 | 3 | 27575556 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 24023293 | ||
| Pubmed | Determining the differences in actin binding by human ADF and cofilin. | 7.19e-07 | 2 | 30 | 2 | 11812157 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 21894436 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 8800436 | ||
| Pubmed | The ADF/cofilin proteins: stimulus-responsive modulators of actin dynamics. | 7.19e-07 | 2 | 30 | 2 | 8589446 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 17196218 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 14627701 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 12049672 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 34169836 | ||
| Pubmed | N-cofilin can compensate for the loss of ADF in excitatory synapses. | 7.19e-07 | 2 | 30 | 2 | 22046357 | |
| Pubmed | Proteomic profiling identifies an UV-induced activation of cofilin-1 and destrin in human epidermis. | 7.19e-07 | 2 | 30 | 2 | 15816841 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 17583572 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 30662943 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 8195165 | ||
| Pubmed | ADF and Cofilin1 Control Actin Stress Fibers, Nuclear Integrity, and Cell Survival. | 7.19e-07 | 2 | 30 | 2 | 26655907 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 15548599 | ||
| Pubmed | ADF/cofilin regulates secretory cargo sorting at the TGN via the Ca2+ ATPase SPCA1. | 2.16e-06 | 3 | 30 | 2 | 21571222 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 23395798 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 20873970 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 24768258 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 18808680 | ||
| Pubmed | ADF/n-cofilin-dependent actin turnover determines platelet formation and sizing. | 2.16e-06 | 3 | 30 | 2 | 20530287 | |
| Pubmed | Dephosphorylation of serine 3 regulates nuclear translocation of cofilin. | 2.16e-06 | 3 | 30 | 2 | 8824278 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 26878213 | ||
| Pubmed | HIV-1 Nef interferes with host cell motility by deregulation of Cofilin. | 2.16e-06 | 3 | 30 | 2 | 19683683 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 26166299 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 20801873 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 22450169 | ||
| Pubmed | Expression of cofilin isoforms during development of mouse striated muscles. | 4.31e-06 | 4 | 30 | 2 | 10813634 | |
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 12684437 | ||
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 23093407 | ||
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 17875668 | ||
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 21060807 | ||
| Pubmed | Actin at stereocilia tips is regulated by mechanotransduction and ADF/cofilin. | 7.18e-06 | 5 | 30 | 2 | 33400922 | |
| Pubmed | 1.08e-05 | 6 | 30 | 2 | 11418599 | ||
| Pubmed | Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. | 1.08e-05 | 6 | 30 | 2 | 10436159 | |
| Pubmed | Nf1 RasGAP inhibition of LIMK2 mediates a new cross-talk between Ras and Rho pathways. | 1.08e-05 | 6 | 30 | 2 | 23082153 | |
| Pubmed | 1.08e-05 | 6 | 30 | 2 | 11832213 | ||
| Pubmed | 1.08e-05 | 6 | 30 | 2 | 26040287 | ||
| Pubmed | Cofilin phosphorylation by LIM-kinase 1 and its role in Rac-mediated actin reorganization. | 1.08e-05 | 6 | 30 | 2 | 9655398 | |
| Pubmed | 1.08e-05 | 6 | 30 | 2 | 25915128 | ||
| Pubmed | 1.08e-05 | 6 | 30 | 2 | 15649475 | ||
| Pubmed | 1.47e-05 | 55 | 30 | 3 | 18448421 | ||
| Pubmed | 1.51e-05 | 7 | 30 | 2 | 38713765 | ||
| Pubmed | Activation of LIM kinases by myotonic dystrophy kinase-related Cdc42-binding kinase alpha. | 2.01e-05 | 8 | 30 | 2 | 11340065 | |
| Pubmed | 2.58e-05 | 9 | 30 | 2 | 18775311 | ||
| Pubmed | 2.58e-05 | 9 | 30 | 2 | 19808661 | ||
| Pubmed | 3.94e-05 | 11 | 30 | 2 | 16815975 | ||
| Pubmed | N-terminal Slit2 inhibits HIV-1 replication by regulating the actin cytoskeleton. | 3.94e-05 | 11 | 30 | 2 | 23294842 | |
| Pubmed | Cofilin and Vangl2 cooperate in the initiation of planar cell polarity in the mouse embryo. | 4.72e-05 | 12 | 30 | 2 | 23406901 | |
| Pubmed | 5.58e-05 | 13 | 30 | 2 | 27597235 | ||
| Pubmed | Loss of ARHGEF6 Causes Hair Cell Stereocilia Deficits and Hearing Loss in Mice. | 5.58e-05 | 13 | 30 | 2 | 30333726 | |
| Pubmed | Clarifying the role of G protein signaling in HIV infection: new approaches to an old question. | 8.57e-05 | 16 | 30 | 2 | 20842205 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | 8.88e-05 | 1284 | 30 | 7 | 17353931 | |
| Pubmed | 1.09e-04 | 18 | 30 | 2 | 24840128 | ||
| Pubmed | HSPB7 is indispensable for heart development by modulating actin filament assembly. | 1.09e-04 | 18 | 30 | 2 | 29078393 | |
| Pubmed | The tumour suppressor PTEN mediates a negative regulation of the E3 ubiquitin-protein ligase Nedd4. | 1.17e-04 | 110 | 30 | 3 | 18307411 | |
| Pubmed | Modifications in the human T cell proteome induced by intracellular HIV-1 Tat protein expression. | 1.64e-04 | 22 | 30 | 2 | 16526095 | |
| Pubmed | Role of the focal adhesion protein TRIM15 in colon cancer development. | 2.13e-04 | 25 | 30 | 2 | 25450970 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 2.22e-04 | 1489 | 30 | 7 | 28611215 | |
| Pubmed | 2.84e-04 | 689 | 30 | 5 | 36543142 | ||
| Pubmed | 2.88e-04 | 29 | 30 | 2 | 30228103 | ||
| Pubmed | 3.29e-04 | 156 | 30 | 3 | 22952844 | ||
| Pubmed | 3.30e-04 | 1116 | 30 | 6 | 31753913 | ||
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | 3.46e-04 | 719 | 30 | 5 | 35337019 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 3.85e-04 | 736 | 30 | 5 | 29676528 | |
| Pubmed | 4.40e-04 | 418 | 30 | 4 | 35338135 | ||
| Pubmed | 6.08e-04 | 814 | 30 | 5 | 23251661 | ||
| Pubmed | 7.27e-04 | 46 | 30 | 2 | 19190083 | ||
| Pubmed | 7.75e-04 | 859 | 30 | 5 | 31536960 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 8.51e-04 | 877 | 30 | 5 | 20211142 | |
| Interaction | LDHAL6A interactions | 3.05e-05 | 41 | 30 | 3 | int:LDHAL6A | |
| Interaction | CFL2 interactions | 3.10e-05 | 122 | 30 | 4 | int:CFL2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p13 | 8.37e-04 | 65 | 30 | 2 | chr11p13 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.40e-06 | 181 | 30 | 4 | b7c85fbef3c06d5dc32a2a58f8d3dfabf1d79d9f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.59e-06 | 189 | 30 | 4 | c9565e962a13a7713056ec3dbb1b67d24f9889c7 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.59e-06 | 189 | 30 | 4 | f75cebd4c3e54e297557449ba67ccc8d1a2a14f5 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast-(8)_Smooth_muscle_cells|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.94e-06 | 197 | 30 | 4 | 4e0c3ea4f4a04a41532806edf3bccf7845c86fa5 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Mesenchymal|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.64e-04 | 159 | 30 | 3 | f34f2729a3872fbb2939e76ad35d7e25f71b8f57 | |
| ToppCell | IIF-Lymphocyte-T_NK-CD4_CTL|IIF / Disease, Lineage and Cell Type | 1.64e-04 | 159 | 30 | 3 | 64e2b57e09bf25b2582f154375bb88cfd02a2521 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Mesenchymal-Unfolded_protein_responsible_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.64e-04 | 159 | 30 | 3 | 929ed98f6c2ad14e8d5af5c6f11a5a3d4b388cf7 | |
| ToppCell | severe-HSPC|World / disease stage, cell group and cell class | 1.96e-04 | 169 | 30 | 3 | b0421b73bfdc92f7a2762b4b670b9eae124aa702 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-04 | 171 | 30 | 3 | 95e87987a2332fa646849fb0de785f1e0b8a07dd | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-04 | 171 | 30 | 3 | 36657e277aad75c4f157c1726c48e09b5836cf37 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-CMP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.07e-04 | 172 | 30 | 3 | f18d9f061df3da96e389616abd5edfc269d3adeb | |
| ToppCell | Adult-Epithelial-club_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.25e-04 | 177 | 30 | 3 | d652b7d84fe6aa38319d8d5adc72c70441bd0088 | |
| ToppCell | 21-Trachea-Epithelial-Submucosal_gland|Trachea / Age, Tissue, Lineage and Cell class | 2.29e-04 | 178 | 30 | 3 | 3e406e38eea0d38dc25edecf703c4c89ec6a28e0 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.29e-04 | 178 | 30 | 3 | f7f88879a05b2b5fa92cf5317b76f7a3064d1358 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.32e-04 | 179 | 30 | 3 | 8766a5a066091879f521acfc612abf563ff78808 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.32e-04 | 179 | 30 | 3 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | HSPCs-Neutro_prog.|HSPCs / Lineage and Cell class | 2.36e-04 | 180 | 30 | 3 | 328192f4678dcdc01c806362b225e770d23498d6 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.40e-04 | 181 | 30 | 3 | 0513b9e6673ff7bf8e72ba123ca3794b65d10170 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.44e-04 | 182 | 30 | 3 | fa16e194f04250149c82e86551270b244cbc8af4 | |
| ToppCell | HSPCs-Neutro_prog.|World / Lineage and Cell class | 2.44e-04 | 182 | 30 | 3 | f2512354b90f55bf4172c28084bf52cf79e41d8a | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 2.48e-04 | 183 | 30 | 3 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.48e-04 | 183 | 30 | 3 | e84539978ab4de42e19186aed00f24bb50cbc21f | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.48e-04 | 183 | 30 | 3 | e972432dd4d1bd31bb0982f4df3061e5e152658f | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.52e-04 | 184 | 30 | 3 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-AT1-AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.56e-04 | 185 | 30 | 3 | 68f428e169cfb77de970bdfdeea9b9f16f68d2ba | |
| ToppCell | droplet-Marrow-nan-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-04 | 185 | 30 | 3 | 3dcafbd02b65a2befbb6e6288cb2591e721cddb6 | |
| ToppCell | droplet-Marrow-BM-30m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-04 | 185 | 30 | 3 | 4157cc14b06bb99ee67ac1526622cf546e727efc | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.60e-04 | 186 | 30 | 3 | bdbe290f81106a53c8c30a92fbb385597c62b2ac | |
| ToppCell | LPS_only-Epithelial_alveolar|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.60e-04 | 186 | 30 | 3 | e0a2ea4b46af742bc7c9b2072bb85e27d5c92712 | |
| ToppCell | droplet-Marrow-nan-18m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-04 | 186 | 30 | 3 | 1bb10a6625c0ada3fe0f0adf7b5899d299d2a9c0 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.64e-04 | 187 | 30 | 3 | f18628ffc7ff7c762b8339ba8822cf0c3157f469 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-04 | 187 | 30 | 3 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | droplet-Marrow-nan-21m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-04 | 187 | 30 | 3 | 20b25b0d08550a1e8e997c5ce67d8e34bf7fc398 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.64e-04 | 187 | 30 | 3 | 9225caf66e06ebe57e90d677122acb6498607f36 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.68e-04 | 188 | 30 | 3 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | droplet-Marrow-nan-18m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-04 | 188 | 30 | 3 | 0a874578f5692a896ea3071a17d87cdeb242fb11 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.68e-04 | 188 | 30 | 3 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | droplet-Marrow-nan-18m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-04 | 188 | 30 | 3 | fa7a612b0a2b35de5f76a0408168dabe5db00773 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 2.68e-04 | 188 | 30 | 3 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 2.68e-04 | 188 | 30 | 3 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.68e-04 | 188 | 30 | 3 | 3004e961d214919e08c7cd5f10c3de5cf85b35a3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-04 | 189 | 30 | 3 | 3a295c215b5c18e7c673f92b7af5be523421682c | |
| ToppCell | COVID-19_Severe-HSPC|COVID-19_Severe / disease group, cell group and cell class | 2.72e-04 | 189 | 30 | 3 | 96015439971e2e5b8d6294ca5a6b873c7774e925 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-04 | 189 | 30 | 3 | fc88c51ace7d883c01617f3f9b5fab70cc91cc09 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.72e-04 | 189 | 30 | 3 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-04 | 189 | 30 | 3 | 8ff3c3232eff9de4b5c9b22ecb82bc509d773f58 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-04 | 189 | 30 | 3 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-04 | 189 | 30 | 3 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.72e-04 | 189 | 30 | 3 | 0abc7a4900cc9033bc1be69b770ccc54a6bf41b4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-04 | 189 | 30 | 3 | 532aaf02b364c5c4f58a2021c7c21d86df3875c9 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.72e-04 | 189 | 30 | 3 | c3df0e3c50af8f1cfb4d790e668bd7f42b276992 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-04 | 190 | 30 | 3 | ff3dec5b45c6ea9b5319fb51a0198c6773b7be26 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.77e-04 | 190 | 30 | 3 | b855b8b7d3439023390ca44629c1a99f5d4c6801 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.77e-04 | 190 | 30 | 3 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-04 | 190 | 30 | 3 | 4971857eac9af17d66d673ed2ab7072639f60a10 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T-CytoT_GZMH+-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.81e-04 | 191 | 30 | 3 | b2d0ea24970da09209da9d9dda76e30fbfe22917 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-04 | 191 | 30 | 3 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-04 | 191 | 30 | 3 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-04 | 191 | 30 | 3 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.90e-04 | 193 | 30 | 3 | a402e736440684ebe123673b6b0c6fcd8fa057b2 | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMH+-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.90e-04 | 193 | 30 | 3 | 3184a5f454e3ac5a81f6bacf9bd8f07d9d448fba | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMH+|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.90e-04 | 193 | 30 | 3 | 123d4d13c8944c32bf4a5d7fdc65e3b65aa568ef | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-04 | 194 | 30 | 3 | be869e186386d03ebb670971dd24fa656b4b0edf | |
| ToppCell | tumor_Lung-T/NK_cells-Exhausted_CD8+_T|tumor_Lung / Location, Cell class and cell subclass | 2.94e-04 | 194 | 30 | 3 | 3fdcfd04174e39491d4f1e6276acc9d11e5a4345 | |
| ToppCell | IIF-Lymphocyte-T_NK-CD8_TEM|IIF / Disease, Lineage and Cell Type | 2.94e-04 | 194 | 30 | 3 | f4f7c85963ba52ee7ca2ef5657e60680fe6332fe | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-04 | 194 | 30 | 3 | 4d6c9b016e3a0641954a8ea10c97d1cd76fadd9f | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-natural_killer_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.99e-04 | 195 | 30 | 3 | 49a4f58aac168fc1838bd5d2b202135cd794c28b | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-Exhausted_CD8+_T|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.99e-04 | 195 | 30 | 3 | f2029195d5b655120a9e84074b2583e2d89c0a1d | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Duct|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.99e-04 | 195 | 30 | 3 | fc2a1d84b3d013e5cb9e7b9cdd740e4010897d20 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-04 | 195 | 30 | 3 | c87edbb8c92a0541b6de2632ac2f9cef44c7e304 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-natural_killer_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.99e-04 | 195 | 30 | 3 | 72f42f0be53a2a61f61647118b4883e752d998a5 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.03e-04 | 196 | 30 | 3 | 5159d8625d80c20eb28157b2603c8bde9d377a35 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes-Fibromyocytes_L.2.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.03e-04 | 196 | 30 | 3 | 6b5b7dbcb2cce8a736e44145a01290905876a5e9 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-04 | 196 | 30 | 3 | 9554ac6eb5f381bcde3ba40c32aa3fc340974540 | |
| ToppCell | Bronchial_Brush-Epithelial|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.08e-04 | 197 | 30 | 3 | 272c7f4e582ef57564450540242b0db766b78328 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 3.12e-04 | 198 | 30 | 3 | 6b6572deeca98ccb015f2aa3c5ce27de44445f74 | |
| ToppCell | remission-NK|World / disease stage, cell group and cell class | 3.12e-04 | 198 | 30 | 3 | 383ed78164ad37826100d3de6c3cc14f62e01813 | |
| ToppCell | (200)_CD56+_NK_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 3.12e-04 | 198 | 30 | 3 | 459e841a01a900808707140297c89c1d6a79024f | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / Treatment groups by lineage, cell group, cell type | 3.12e-04 | 198 | 30 | 3 | d087e738d69ca9853553fde46d4e7a8906439d32 | |
| ToppCell | Multiple_Sclerosis|World / Disease, Lineage and Cell Type | 3.12e-04 | 198 | 30 | 3 | 46728bb03f4b0d30ae9b62d984a6c2d00cfd370a | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.12e-04 | 198 | 30 | 3 | e9f434bfd072e590fe44d518057ee5aa653038f3 | |
| ToppCell | (2)_NK/T-(20)_NK_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 3.12e-04 | 198 | 30 | 3 | 2e4851e49457940e841660c5d781499ffb4a2bf1 | |
| ToppCell | (2)_NK/T-(200)_CD56+_NK_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 3.12e-04 | 198 | 30 | 3 | 03477a6356a3c08c6e723165c0aac3464ef01667 | |
| ToppCell | (20)_NK_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 3.12e-04 | 198 | 30 | 3 | 178b885e56e734a4408032ea79c68163333de9b6 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.12e-04 | 198 | 30 | 3 | af07a970afaa435c6433bb5c1cbff4c67af350c7 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 3.17e-04 | 199 | 30 | 3 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-NK_cell-NK|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.17e-04 | 199 | 30 | 3 | fd3706f256e33cf348774bea0ba0df6d41fd96e3 | |
| ToppCell | NS-critical-d_07-13-Epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.17e-04 | 199 | 30 | 3 | b88a81cd2a89f4d27100c96ae4324dcee68daf83 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-NK_cell-NK-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.17e-04 | 199 | 30 | 3 | 252f0084fa17770f4c34e21066519d7f7cad75d9 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-NK_cell-NK|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.17e-04 | 199 | 30 | 3 | 899642ff6bb6c1612f14a9a049b4344ae694752a | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-NK_cell-NK-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.17e-04 | 199 | 30 | 3 | e981b159841222a6838effff1059c683c20ecf5b | |
| ToppCell | critical-Epithelial|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.17e-04 | 199 | 30 | 3 | bbb44e2a52f102a6d891ead6c06d6c07221abd33 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.17e-04 | 199 | 30 | 3 | 8f2b57cf2f932f20ea029132d8bda01aac774571 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-NK_cell|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.17e-04 | 199 | 30 | 3 | 8cdd5aa30a8112b77f5d02b40c45b63f541e1476 | |
| ToppCell | COVID-19_Convalescent-Lymphoid_T/NK-NK|COVID-19_Convalescent / Disease group, lineage and cell class | 3.17e-04 | 199 | 30 | 3 | 9809d996a2c3f5384707646a3929e1d6b85dcdc2 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-NK_cell|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.17e-04 | 199 | 30 | 3 | a2ac6af5e8e13e7edd3302ebdb175a3902bfb2bc | |
| ToppCell | COVID-19_Mild-CD4+_CTL|COVID-19_Mild / Disease condition and Cell class | 3.17e-04 | 199 | 30 | 3 | a6b408fa84a47ca8208e48938026a980ccd3ea25 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 3.17e-04 | 199 | 30 | 3 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | remission-NK|remission / disease stage, cell group and cell class | 3.17e-04 | 199 | 30 | 3 | 31ed2a314e8f70980ea0686242446d66929288e9 | |
| ToppCell | 15-Trachea-Epithelial|Trachea / Age, Tissue, Lineage and Cell class | 3.17e-04 | 199 | 30 | 3 | e0099aa95cf3ec08d7688cc97f4b917fce65a7a3 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 6.29e-05 | 165 | 30 | 4 | 5625_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 6.59e-05 | 167 | 30 | 4 | 3979_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 6.75e-05 | 168 | 30 | 4 | 3395_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 6.91e-05 | 169 | 30 | 4 | 5231_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 7.07e-05 | 170 | 30 | 4 | 7043_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 7.07e-05 | 170 | 30 | 4 | 5260_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 7.07e-05 | 170 | 30 | 4 | 3791_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 7.07e-05 | 170 | 30 | 4 | 4153_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 7.23e-05 | 171 | 30 | 4 | 5441_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 7.39e-05 | 172 | 30 | 4 | 4112_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 7.56e-05 | 173 | 30 | 4 | 5336_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 7.56e-05 | 173 | 30 | 4 | 2881_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 7.73e-05 | 174 | 30 | 4 | 3993_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 7.73e-05 | 174 | 30 | 4 | 3462_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 7.73e-05 | 174 | 30 | 4 | 5945_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 7.73e-05 | 174 | 30 | 4 | 5693_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 7.73e-05 | 174 | 30 | 4 | 5065_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 7.91e-05 | 175 | 30 | 4 | 4072_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 7.91e-05 | 175 | 30 | 4 | 3787_DN | |
| Drug | Rifabutin [72559-06-9]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 7.91e-05 | 175 | 30 | 4 | 3873_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.08e-05 | 176 | 30 | 4 | 6784_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.26e-05 | 177 | 30 | 4 | 3227_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.26e-05 | 177 | 30 | 4 | 3177_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 8.44e-05 | 178 | 30 | 4 | 4436_DN | |
| Drug | SAHA; Down 200; 10uM; PC3; HT_HG-U133A | 8.44e-05 | 178 | 30 | 4 | 4444_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 8.82e-05 | 180 | 30 | 4 | 3688_DN | |
| Drug | C04424 | 9.16e-05 | 11 | 30 | 2 | CID011953835 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 9.40e-05 | 183 | 30 | 4 | 4770_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 1.00e-04 | 186 | 30 | 4 | 6874_DN | |
| Drug | Azacytidine-5 [320-67-2]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 1.09e-04 | 190 | 30 | 4 | 4128_DN | |
| Drug | C05118 | 1.10e-04 | 12 | 30 | 2 | CID000440565 | |
| Drug | C05119 | 1.10e-04 | 12 | 30 | 2 | CID000440566 | |
| Drug | Nomifensine maleate [32795-47-4]; Down 200; 11.2uM; PC3; HT_HG-U133A | 1.27e-04 | 198 | 30 | 4 | 2062_DN | |
| Drug | SB 202190; Down 200; 1uM; PC3; HT_HG-U133A | 1.30e-04 | 199 | 30 | 4 | 6882_DN | |
| Drug | AS-6 | 2.53e-04 | 18 | 30 | 2 | CID006438999 | |
| Disease | nemaline myopathy 7 (implicated_via_orthology) | 9.99e-07 | 2 | 30 | 2 | DOID:0110934 (implicated_via_orthology) | |
| Disease | body weight | 2.19e-04 | 1261 | 30 | 7 | EFO_0004338 | |
| Disease | Anxiety Disorders | 9.21e-04 | 44 | 30 | 2 | C0003469 | |
| Disease | Anxiety neurosis (finding) | 9.21e-04 | 44 | 30 | 2 | C1279420 | |
| Disease | Anxiety States, Neurotic | 9.21e-04 | 44 | 30 | 2 | C0376280 | |
| Disease | osteoarthritis | 1.47e-03 | 222 | 30 | 3 | MONDO_0005178 | |
| Disease | non-lobar intracerebral hemorrhage | 1.88e-03 | 63 | 30 | 2 | EFO_0010178 | |
| Disease | cortical surface area measurement | 2.05e-03 | 1345 | 30 | 6 | EFO_0010736 | |
| Disease | cortical thickness | 4.92e-03 | 1113 | 30 | 5 | EFO_0004840 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KKTSDSKYPMKRITK | 1281 | Q68DN1 | |
| KRMLLTLKSNKYKSS | 531 | Q76B58 | |
| LKSKMIYASSKDAIK | 111 | P23528 | |
| KKSSMAKLYKGLASQ | 456 | A8MVX0 | |
| LKSKMIYASSKDAIK | 111 | P60981 | |
| TMTTLYIQQLKSKKK | 121 | Q6ZS30 | |
| RSLKGKLMNSKKLSS | 1406 | Q7Z5J4 | |
| MNGKAYNKKTLRTSK | 1636 | Q2KHR3 | |
| KYMKSKNILLRHSKK | 756 | Q8WYB5 | |
| LLSLKKKMKVPYLSS | 326 | Q7Z5J8 | |
| VQKSKLSLYKKAMES | 126 | O43586 | |
| RLQYEKKLKSTKSLM | 221 | Q86W92 | |
| SRVLRMKKKKTKYTS | 796 | Q2KJY2 | |
| LKSKMIYASSKDAIK | 111 | Q9Y281 | |
| YLALQKASMASLKKT | 391 | Q4G0J3 | |
| KKKNNSSMTYEKLSR | 251 | Q9NZC4 | |
| LLKFSQLKSSMKLSK | 811 | Q0VDD8 | |
| SPSTSLKSIMKKKDY | 636 | Q5T7N3 | |
| YFMSSTLKKLLNKTN | 686 | Q8IWA5 | |
| KVLKLYKSMTLLNTM | 101 | P12694 | |
| SSKVLFRKSEKYMKL | 381 | Q9H720 | |
| MSKRYLQKATKGKLL | 1 | Q8N3H0 | |
| YLKNFNMTKKKARSI | 186 | Q03181 | |
| YLSGKLFNKSKMKLT | 541 | O43490 | |
| LSRHLMKVKLKKYTK | 226 | Q9NRB3 | |
| TKMALNYKSKSQKRS | 266 | Q9Y2G3 | |
| YGIKKNSLSSIMKNK | 46 | Q8IY51 | |
| KSTRKVYAMKLLSKF | 96 | Q13464 | |
| SSRKKMKISFNDKSL | 571 | Q4KMQ1 | |
| KEYISNKRKSMTKLR | 646 | P17480 | |
| MKKISLKTLRKSFNL | 1 | O14544 |